Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus

YongBeom Park, S. K. Lee, D. S. Kim, J. Lee, C. H. Lee, C. H. Song

Research output: Contribution to journalArticle

202 Citations (Scopus)

Abstract

Objective: To determine serum interleukin-10 (IL-10) levels in systemic lupus erythematosus (SLE) patients and to assess their relationship with disease activity. Methods: Forty-one SLE patients and 35 controls were studied. Paired serum samples were collected from all SLE patients at the time of their presentation with active disease and at 4 weeks after the institution of treatment. IL-10 levels were determined in the sera and were compared with disease activity, measured using the SLE Disease Activity Index (SLEDAI) and laboratory parameters such as the circulating immune complexes (CIC), C3, C4, anti-DNA antibody, IgG, IgM, and IgA. Results: The IL-10 levels in SLE patients were significantly higher than those of controls (mean ± SE, 29.2 ± 6.8 vs 3.5 ± 0.6 pg/ml, p < 0.01). Elevated IL-10 levels correlated well with the SLEDAI in SLE patients (r = 0.46, p < 0.01), but did not correlate with other laboratory activity indices. The changes in serum IL-10 levels also correlated with the changes in the SLEDAI score during the patients' disease course (r = 0.51, p < 0.01). Conclusion: Serum levels of IL-10 are elevated in SLE patients and increased IL-10 correlates well with SLE disease activity.

Original languageEnglish
Pages (from-to)283-288
Number of pages6
JournalClinical and Experimental Rheumatology
Volume16
Issue number3
Publication statusPublished - 1998 May 25

Fingerprint

Systemic Lupus Erythematosus
Interleukin-10
Serum
Antinuclear Antibodies
Antigen-Antibody Complex
Immunoglobulin A
Immunoglobulin M
Immunoglobulin G

All Science Journal Classification (ASJC) codes

  • Rheumatology
  • Immunology and Allergy
  • Immunology

Cite this

Park, YongBeom ; Lee, S. K. ; Kim, D. S. ; Lee, J. ; Lee, C. H. ; Song, C. H. / Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus. In: Clinical and Experimental Rheumatology. 1998 ; Vol. 16, No. 3. pp. 283-288.
@article{868e212d835b416ab4ae50a8f06f489b,
title = "Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus",
abstract = "Objective: To determine serum interleukin-10 (IL-10) levels in systemic lupus erythematosus (SLE) patients and to assess their relationship with disease activity. Methods: Forty-one SLE patients and 35 controls were studied. Paired serum samples were collected from all SLE patients at the time of their presentation with active disease and at 4 weeks after the institution of treatment. IL-10 levels were determined in the sera and were compared with disease activity, measured using the SLE Disease Activity Index (SLEDAI) and laboratory parameters such as the circulating immune complexes (CIC), C3, C4, anti-DNA antibody, IgG, IgM, and IgA. Results: The IL-10 levels in SLE patients were significantly higher than those of controls (mean ± SE, 29.2 ± 6.8 vs 3.5 ± 0.6 pg/ml, p < 0.01). Elevated IL-10 levels correlated well with the SLEDAI in SLE patients (r = 0.46, p < 0.01), but did not correlate with other laboratory activity indices. The changes in serum IL-10 levels also correlated with the changes in the SLEDAI score during the patients' disease course (r = 0.51, p < 0.01). Conclusion: Serum levels of IL-10 are elevated in SLE patients and increased IL-10 correlates well with SLE disease activity.",
author = "YongBeom Park and Lee, {S. K.} and Kim, {D. S.} and J. Lee and Lee, {C. H.} and Song, {C. H.}",
year = "1998",
month = "5",
day = "25",
language = "English",
volume = "16",
pages = "283--288",
journal = "Clinical and Experimental Rheumatology",
issn = "0392-856X",
publisher = "Clinical and Experimental Rheumatology S.A.S.",
number = "3",

}

Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus. / Park, YongBeom; Lee, S. K.; Kim, D. S.; Lee, J.; Lee, C. H.; Song, C. H.

In: Clinical and Experimental Rheumatology, Vol. 16, No. 3, 25.05.1998, p. 283-288.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus

AU - Park, YongBeom

AU - Lee, S. K.

AU - Kim, D. S.

AU - Lee, J.

AU - Lee, C. H.

AU - Song, C. H.

PY - 1998/5/25

Y1 - 1998/5/25

N2 - Objective: To determine serum interleukin-10 (IL-10) levels in systemic lupus erythematosus (SLE) patients and to assess their relationship with disease activity. Methods: Forty-one SLE patients and 35 controls were studied. Paired serum samples were collected from all SLE patients at the time of their presentation with active disease and at 4 weeks after the institution of treatment. IL-10 levels were determined in the sera and were compared with disease activity, measured using the SLE Disease Activity Index (SLEDAI) and laboratory parameters such as the circulating immune complexes (CIC), C3, C4, anti-DNA antibody, IgG, IgM, and IgA. Results: The IL-10 levels in SLE patients were significantly higher than those of controls (mean ± SE, 29.2 ± 6.8 vs 3.5 ± 0.6 pg/ml, p < 0.01). Elevated IL-10 levels correlated well with the SLEDAI in SLE patients (r = 0.46, p < 0.01), but did not correlate with other laboratory activity indices. The changes in serum IL-10 levels also correlated with the changes in the SLEDAI score during the patients' disease course (r = 0.51, p < 0.01). Conclusion: Serum levels of IL-10 are elevated in SLE patients and increased IL-10 correlates well with SLE disease activity.

AB - Objective: To determine serum interleukin-10 (IL-10) levels in systemic lupus erythematosus (SLE) patients and to assess their relationship with disease activity. Methods: Forty-one SLE patients and 35 controls were studied. Paired serum samples were collected from all SLE patients at the time of their presentation with active disease and at 4 weeks after the institution of treatment. IL-10 levels were determined in the sera and were compared with disease activity, measured using the SLE Disease Activity Index (SLEDAI) and laboratory parameters such as the circulating immune complexes (CIC), C3, C4, anti-DNA antibody, IgG, IgM, and IgA. Results: The IL-10 levels in SLE patients were significantly higher than those of controls (mean ± SE, 29.2 ± 6.8 vs 3.5 ± 0.6 pg/ml, p < 0.01). Elevated IL-10 levels correlated well with the SLEDAI in SLE patients (r = 0.46, p < 0.01), but did not correlate with other laboratory activity indices. The changes in serum IL-10 levels also correlated with the changes in the SLEDAI score during the patients' disease course (r = 0.51, p < 0.01). Conclusion: Serum levels of IL-10 are elevated in SLE patients and increased IL-10 correlates well with SLE disease activity.

UR - http://www.scopus.com/inward/record.url?scp=0031961344&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031961344&partnerID=8YFLogxK

M3 - Article

VL - 16

SP - 283

EP - 288

JO - Clinical and Experimental Rheumatology

JF - Clinical and Experimental Rheumatology

SN - 0392-856X

IS - 3

ER -